קסלודה 150 מ"ג

Nchi: Israeli

Lugha: Kiebrania

Chanzo: Ministry of Health

Viambatanisho vya kazi:

CAPECITABINE 150 MG

Inapatikana kutoka:

ROCHE PHARMACEUTICALS (ISRAEL) LTD

ATC kanuni:

L01BC06

Dawa fomu:

FILM COATED TABLETS

Njia ya uendeshaji:

PER OS

Viwandani na:

HOFFMANN LA ROCHE LTD, SWITZERLAND

Kundi la matibabu:

CAPECITABINE

Matibabu dalili:

Adjuvant Colon Cancer: Xeloda is indicated for the adjuvant treatment of patients following surgery of stage III (Dukesע stage C) colon cancer. Colorectal Cancer: Xeloda is indicated for the treatment of patients with advanced or metastatic colorectal cancer Advanced gastric cancer: Xeloda is indicated for first line treatment of advanced gastric cancer in combination with chemotherapy Breast Cancer Combination Therapy: Xeloda in combination with docetaxel is indicated for the treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing chemotherapy. Breast Cancer Monotherapy: Xeloda is also indicated for the treatment of advanced or metastatic breast cancer after failure of standard therapy including a taxane unless therapy with a taxane is clinically contraindicated.

Idhini ya tarehe:

2010-06-01